Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatment modalities for heart failure and related cardiovascular conditions. Its lead product, the Carillon Mitral Contour System, uses a gentle, minimally invasive approach. It designed the system to restore natural mitral valve function without damaging mitral valve leaflets.
According to a news release, the device offers favorable remodeling while reducing mitral regurgitation. Cardiac Dimensions said it improves quality of life and extends survival for a range of patients.
Carillon produces an annuloplasty effect while initiating left ventricular remodeling and improving long-term survival. It can accompany other heart failure treatments if needed, Cardiac Dimensions said.
Existing investor Horiz…